Literature DB >> 17916797

Antibody microarray analysis of inflammatory mediator release by human leukemia T-cells and human non small cell lung cancer cells.

Bradley H Garcia1, Aubrey Hargrave, Aric Morgan, Greg Kilmer, Eric Hommema, Janaki Nahrahari, Brian Webb, Rick Wiese.   

Abstract

Cytokines and chemokines are responsible for regulating inflammation and the immune response. Cytokine and chemokine release is typically measured by quantitative enzyme-linked immunosorbant assay (ELISA) or Western blot analysis. To expedite the analysis of samples for multiple cytokines/chemokines, we have developed slide-based Thermo Scientific ExcelArray Antibody Sandwich Microarrays. Each slide consists of 16 subarrays (wells), each printed with 12 specific antibodies in triplicate and positive and negative control elements. This 16-well format allows for the analysis of 10 test samples using a six-point standard curve. The array architecture is based on the "sandwich" ELISA, in which an analyte protein is sandwiched between an immobilized capture antibody and a biotinylated detection antibody, using streptavidin-linked Thermo Scientific DyLight 649 Dye for quantitation. The observed sensitivity of this assay was <10 pg/mL. In our experiments, the Jurkat cell line was used as a model for human T-cell leukemia, and the A549 cell line was used as a model for human non-small cell lung cancer. To evoke a cytokine/chemokine response, cells were stimulated with tumor necrosis factor alpha (TNFalpha), phorbol-12-myristate-13-acetate (PMA, TPA), and phytohemagglutinin (PHA). Cell supernatants derived from both untreated and stimulated cells were analyzed on four different arrays (Inflammation I, Inflammation II, Angiogenesis, and Chemotaxis), enabling the quantitation of 41 unique analytes. Stimulated cells showed an increase in the expression level of many of the test analytes, including IL-8, TNF-alpha, and MIP-1alpha, compared to the non-treated controls. Our experiments clearly demonstrate the utility of antibody microarray analysis of cell-culture supernatants for the profiling of cellular inflammatory mediator release.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916797      PMCID: PMC2062556     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  11 in total

1.  High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA).

Authors:  L G Mendoza; P McQuary; A Mongan; R Gangadharan; S Brignac; M Eggers
Journal:  Biotechniques       Date:  1999-10       Impact factor: 1.993

2.  Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays.

Authors:  Sun W Tam; Rick Wiese; Sandy Lee; James Gilmore; Krishnanand D Kumble
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

3.  Microarrays: their origins and applications.

Authors:  R Ekins; F W Chu
Journal:  Trends Biotechnol       Date:  1999-06       Impact factor: 19.536

4.  Protein microarrays for gene expression and antibody screening.

Authors:  A Lueking; M Horn; H Eickhoff; K Büssow; H Lehrach; G Walter
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

5.  Array of hope.

Authors:  E S Lander
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

6.  Simultaneous multianalyte ELISA performed on a microarray platform.

Authors:  R Wiese; Y Belosludtsev; T Powdrill; P Thompson; M Hogan
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

7.  Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes.

Authors:  Yosuke Osawa; Masahito Nagaki; Yoshiko Banno; David A Brenner; Takahiko Asano; Yoshinori Nozawa; Hisataka Moriwaki; Shigeru Nakashima
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells.

Authors:  Katalin Erdèlyi; Andrea Kiss; Edina Bakondi; Péter Bai; Csaba Szabó; Pál Gergely; Ferenc Erdödi; László Virag
Journal:  Mol Pharmacol       Date:  2005-06-23       Impact factor: 4.436

9.  The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis.

Authors:  D M Gerlag; L Ransone; P P Tak; Z Han; M Palanki; M S Barbosa; D Boyle; A M Manning; G S Firestein
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.426

10.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions.

Authors:  B B Haab; M J Dunham; P O Brown
Journal:  Genome Biol       Date:  2001-01-22       Impact factor: 13.583

View more
  5 in total

1.  Collagen-related biomarkers in severe sepsis: a big stretch?

Authors:  Gavin Morrison; Douglas D Fraser
Journal:  Crit Care       Date:  2009-06-02       Impact factor: 9.097

Review 2.  Facing current quantification challenges in protein microarrays.

Authors:  Robert Wellhausen; Harald Seitz
Journal:  J Biomed Biotechnol       Date:  2012-04-24

3.  Human severe sepsis cytokine mixture increases β2-integrin-dependent polymorphonuclear leukocyte adhesion to cerebral microvascular endothelial cells in vitro.

Authors:  Chris Blom; Brittany L Deller; Douglas D Fraser; Eric K Patterson; Claudio M Martin; Bryan Young; Patricia C Liaw; Payam Yazdan-Ashoori; Angelica Ortiz; Brian Webb; Greg Kilmer; David E Carter; Gediminas Cepinskas
Journal:  Crit Care       Date:  2015-04-07       Impact factor: 9.097

4.  Aqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes.

Authors:  Paul R Hanlon; Melissa G Robbins; Chris Scholl; David M Barnes
Journal:  BMC Complement Altern Med       Date:  2009-12-14       Impact factor: 3.659

5.  FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.

Authors:  D J Mulder; I Pacheco; D J Hurlbut; N Mak; G T Furuta; R J MacLeod; C J Justinich
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.